Non-hodgkin's lymphoma of the ocular adnexa
This study investigates the relationship between the clinical features of lymphoma in the ocular adnexal region and the revised European and American lymphoma (REAL) classification. Specimens from 41 patients with ocular adnexal lymphoproliferative disease were reassessed pathologically using the RE...
Gespeichert in:
| Veröffentlicht in: | Acta oncologica 2001-01, Vol.40 (4), p.485-490 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 490 |
|---|---|
| container_issue | 4 |
| container_start_page | 485 |
| container_title | Acta oncologica |
| container_volume | 40 |
| creator | SASAI, Keisuke YAMABE, Hirohiko DODO, Yoshihiro KASHII, Satoshi NAGATA, Yasushi HIRAOKA, Masahiro |
| description | This study investigates the relationship between the clinical features of lymphoma in the ocular adnexal region and the revised European and American lymphoma (REAL) classification. Specimens from 41 patients with ocular adnexal lymphoproliferative disease were reassessed pathologically using the REAL classification. Thirty-two patients with primary non-Hodgkin's lymphomas (NHL) were included in the study, almost all of them having been treated with radiotherapy with or without chemotherapy. Seven of the 32 patients with NHL showed distant recurrence after treatment: 3 out of 26 with extranodal marginal zone B-cell lymphoma, and 4 with other types of NHL. Although the three patients with recurrent marginal zone B-cell lymphomas all survived, other patients with recurrent lymphomas died of disease. The REAL classification provides a good indication of tumor control probability and survival of patients with ocular adnexal NHL. Radiation therapy is an effective treatment modality for extranodal marginal zone B-cell lymphoma of the ocular adnexa. |
| doi_str_mv | 10.1080/028418601750288217 |
| format | Article |
| fullrecord | <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1080_028418601750288217</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>11504308</sourcerecordid><originalsourceid>FETCH-LOGICAL-c329t-4c59503a44a6b7ebc78b6fddbda7ec01f280899e4523e09f4837a779cf5964d93</originalsourceid><addsrcrecordid>eNplj0tLw0AURgdRbKz-AReSjbiQ6J1XZmYpxRcU3Sh0F27mYat5kWnB_ntTGujC1b2Lcz44hFxSuKOg4R6YFlTnQJUcXs2oOiIJzSXNGMsXxyTZAdlALCbkLMZvAGBcyVMyoVSC4KATcvvWNtmydV8_q-YmptW27pZtjWkb0vXSp63dVNin6Br_i-fkJGAV_cV4p-Tz6fFj9pLN359fZw_zzHJm1pmw0kjgKATmpfKlVbrMg3OlQ-Ut0MA0aGO8kIx7MEForlApY4M0uXCGTwnb79q-jbH3oej6VY39tqBQ7MqL_-WDdLWXuk1Ze3dQxtQBuB4BjBar0GNjV_HAiWFYceB_BltezQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Non-hodgkin's lymphoma of the ocular adnexa</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Taylor & Francis Journals Complete</source><creator>SASAI, Keisuke ; YAMABE, Hirohiko ; DODO, Yoshihiro ; KASHII, Satoshi ; NAGATA, Yasushi ; HIRAOKA, Masahiro</creator><creatorcontrib>SASAI, Keisuke ; YAMABE, Hirohiko ; DODO, Yoshihiro ; KASHII, Satoshi ; NAGATA, Yasushi ; HIRAOKA, Masahiro</creatorcontrib><description>This study investigates the relationship between the clinical features of lymphoma in the ocular adnexal region and the revised European and American lymphoma (REAL) classification. Specimens from 41 patients with ocular adnexal lymphoproliferative disease were reassessed pathologically using the REAL classification. Thirty-two patients with primary non-Hodgkin's lymphomas (NHL) were included in the study, almost all of them having been treated with radiotherapy with or without chemotherapy. Seven of the 32 patients with NHL showed distant recurrence after treatment: 3 out of 26 with extranodal marginal zone B-cell lymphoma, and 4 with other types of NHL. Although the three patients with recurrent marginal zone B-cell lymphomas all survived, other patients with recurrent lymphomas died of disease. The REAL classification provides a good indication of tumor control probability and survival of patients with ocular adnexal NHL. Radiation therapy is an effective treatment modality for extranodal marginal zone B-cell lymphoma of the ocular adnexa.</description><identifier>ISSN: 0284-186X</identifier><identifier>EISSN: 1651-226X</identifier><identifier>DOI: 10.1080/028418601750288217</identifier><identifier>PMID: 11504308</identifier><identifier>CODEN: ACTOEL</identifier><language>eng</language><publisher>Basingstoke: Taylor & Francis</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Antineoplastic Combined Chemotherapy Protocols - administration & dosage ; Antineoplastic Combined Chemotherapy Protocols - therapeutic use ; Biological and medical sciences ; Chemotherapy, Adjuvant ; Cohort Studies ; Combined Modality Therapy ; Conjunctival Neoplasms - drug therapy ; Conjunctival Neoplasms - epidemiology ; Conjunctival Neoplasms - pathology ; Conjunctival Neoplasms - radiotherapy ; Cyclophosphamide - administration & dosage ; Disease-Free Survival ; Doxorubicin - administration & dosage ; Eyelid Neoplasms - drug therapy ; Eyelid Neoplasms - epidemiology ; Eyelid Neoplasms - pathology ; Eyelid Neoplasms - radiotherapy ; Female ; Hematologic and hematopoietic diseases ; Humans ; Immunoenzyme Techniques ; Immunophenotyping ; Japan - epidemiology ; Lacrimal Apparatus Diseases - drug therapy ; Lacrimal Apparatus Diseases - epidemiology ; Lacrimal Apparatus Diseases - pathology ; Lacrimal Apparatus Diseases - radiotherapy ; Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis ; Life Tables ; Lymphoma, Non-Hodgkin - drug therapy ; Lymphoma, Non-Hodgkin - epidemiology ; Lymphoma, Non-Hodgkin - pathology ; Lymphoma, Non-Hodgkin - radiotherapy ; Lymphoproliferative Disorders - epidemiology ; Lymphoproliferative Disorders - pathology ; Male ; Medical sciences ; Middle Aged ; Neoplasm Staging ; Orbital Neoplasms - drug therapy ; Orbital Neoplasms - epidemiology ; Orbital Neoplasms - pathology ; Orbital Neoplasms - radiotherapy ; Prednisone - administration & dosage ; Radiotherapy, High-Energy - adverse effects ; Retrospective Studies ; Survival Analysis ; Treatment Outcome ; Vincristine - administration & dosage</subject><ispartof>Acta oncologica, 2001-01, Vol.40 (4), p.485-490</ispartof><rights>2002 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c329t-4c59503a44a6b7ebc78b6fddbda7ec01f280899e4523e09f4837a779cf5964d93</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=14080730$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11504308$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>SASAI, Keisuke</creatorcontrib><creatorcontrib>YAMABE, Hirohiko</creatorcontrib><creatorcontrib>DODO, Yoshihiro</creatorcontrib><creatorcontrib>KASHII, Satoshi</creatorcontrib><creatorcontrib>NAGATA, Yasushi</creatorcontrib><creatorcontrib>HIRAOKA, Masahiro</creatorcontrib><title>Non-hodgkin's lymphoma of the ocular adnexa</title><title>Acta oncologica</title><addtitle>Acta Oncol</addtitle><description>This study investigates the relationship between the clinical features of lymphoma in the ocular adnexal region and the revised European and American lymphoma (REAL) classification. Specimens from 41 patients with ocular adnexal lymphoproliferative disease were reassessed pathologically using the REAL classification. Thirty-two patients with primary non-Hodgkin's lymphomas (NHL) were included in the study, almost all of them having been treated with radiotherapy with or without chemotherapy. Seven of the 32 patients with NHL showed distant recurrence after treatment: 3 out of 26 with extranodal marginal zone B-cell lymphoma, and 4 with other types of NHL. Although the three patients with recurrent marginal zone B-cell lymphomas all survived, other patients with recurrent lymphomas died of disease. The REAL classification provides a good indication of tumor control probability and survival of patients with ocular adnexal NHL. Radiation therapy is an effective treatment modality for extranodal marginal zone B-cell lymphoma of the ocular adnexa.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Antineoplastic Combined Chemotherapy Protocols - administration & dosage</subject><subject>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Chemotherapy, Adjuvant</subject><subject>Cohort Studies</subject><subject>Combined Modality Therapy</subject><subject>Conjunctival Neoplasms - drug therapy</subject><subject>Conjunctival Neoplasms - epidemiology</subject><subject>Conjunctival Neoplasms - pathology</subject><subject>Conjunctival Neoplasms - radiotherapy</subject><subject>Cyclophosphamide - administration & dosage</subject><subject>Disease-Free Survival</subject><subject>Doxorubicin - administration & dosage</subject><subject>Eyelid Neoplasms - drug therapy</subject><subject>Eyelid Neoplasms - epidemiology</subject><subject>Eyelid Neoplasms - pathology</subject><subject>Eyelid Neoplasms - radiotherapy</subject><subject>Female</subject><subject>Hematologic and hematopoietic diseases</subject><subject>Humans</subject><subject>Immunoenzyme Techniques</subject><subject>Immunophenotyping</subject><subject>Japan - epidemiology</subject><subject>Lacrimal Apparatus Diseases - drug therapy</subject><subject>Lacrimal Apparatus Diseases - epidemiology</subject><subject>Lacrimal Apparatus Diseases - pathology</subject><subject>Lacrimal Apparatus Diseases - radiotherapy</subject><subject>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</subject><subject>Life Tables</subject><subject>Lymphoma, Non-Hodgkin - drug therapy</subject><subject>Lymphoma, Non-Hodgkin - epidemiology</subject><subject>Lymphoma, Non-Hodgkin - pathology</subject><subject>Lymphoma, Non-Hodgkin - radiotherapy</subject><subject>Lymphoproliferative Disorders - epidemiology</subject><subject>Lymphoproliferative Disorders - pathology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Neoplasm Staging</subject><subject>Orbital Neoplasms - drug therapy</subject><subject>Orbital Neoplasms - epidemiology</subject><subject>Orbital Neoplasms - pathology</subject><subject>Orbital Neoplasms - radiotherapy</subject><subject>Prednisone - administration & dosage</subject><subject>Radiotherapy, High-Energy - adverse effects</subject><subject>Retrospective Studies</subject><subject>Survival Analysis</subject><subject>Treatment Outcome</subject><subject>Vincristine - administration & dosage</subject><issn>0284-186X</issn><issn>1651-226X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNplj0tLw0AURgdRbKz-AReSjbiQ6J1XZmYpxRcU3Sh0F27mYat5kWnB_ntTGujC1b2Lcz44hFxSuKOg4R6YFlTnQJUcXs2oOiIJzSXNGMsXxyTZAdlALCbkLMZvAGBcyVMyoVSC4KATcvvWNtmydV8_q-YmptW27pZtjWkb0vXSp63dVNin6Br_i-fkJGAV_cV4p-Tz6fFj9pLN359fZw_zzHJm1pmw0kjgKATmpfKlVbrMg3OlQ-Ut0MA0aGO8kIx7MEForlApY4M0uXCGTwnb79q-jbH3oej6VY39tqBQ7MqL_-WDdLWXuk1Ze3dQxtQBuB4BjBar0GNjV_HAiWFYceB_BltezQ</recordid><startdate>20010101</startdate><enddate>20010101</enddate><creator>SASAI, Keisuke</creator><creator>YAMABE, Hirohiko</creator><creator>DODO, Yoshihiro</creator><creator>KASHII, Satoshi</creator><creator>NAGATA, Yasushi</creator><creator>HIRAOKA, Masahiro</creator><general>Taylor & Francis</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20010101</creationdate><title>Non-hodgkin's lymphoma of the ocular adnexa</title><author>SASAI, Keisuke ; YAMABE, Hirohiko ; DODO, Yoshihiro ; KASHII, Satoshi ; NAGATA, Yasushi ; HIRAOKA, Masahiro</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c329t-4c59503a44a6b7ebc78b6fddbda7ec01f280899e4523e09f4837a779cf5964d93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Antineoplastic Combined Chemotherapy Protocols - administration & dosage</topic><topic>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Chemotherapy, Adjuvant</topic><topic>Cohort Studies</topic><topic>Combined Modality Therapy</topic><topic>Conjunctival Neoplasms - drug therapy</topic><topic>Conjunctival Neoplasms - epidemiology</topic><topic>Conjunctival Neoplasms - pathology</topic><topic>Conjunctival Neoplasms - radiotherapy</topic><topic>Cyclophosphamide - administration & dosage</topic><topic>Disease-Free Survival</topic><topic>Doxorubicin - administration & dosage</topic><topic>Eyelid Neoplasms - drug therapy</topic><topic>Eyelid Neoplasms - epidemiology</topic><topic>Eyelid Neoplasms - pathology</topic><topic>Eyelid Neoplasms - radiotherapy</topic><topic>Female</topic><topic>Hematologic and hematopoietic diseases</topic><topic>Humans</topic><topic>Immunoenzyme Techniques</topic><topic>Immunophenotyping</topic><topic>Japan - epidemiology</topic><topic>Lacrimal Apparatus Diseases - drug therapy</topic><topic>Lacrimal Apparatus Diseases - epidemiology</topic><topic>Lacrimal Apparatus Diseases - pathology</topic><topic>Lacrimal Apparatus Diseases - radiotherapy</topic><topic>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</topic><topic>Life Tables</topic><topic>Lymphoma, Non-Hodgkin - drug therapy</topic><topic>Lymphoma, Non-Hodgkin - epidemiology</topic><topic>Lymphoma, Non-Hodgkin - pathology</topic><topic>Lymphoma, Non-Hodgkin - radiotherapy</topic><topic>Lymphoproliferative Disorders - epidemiology</topic><topic>Lymphoproliferative Disorders - pathology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Neoplasm Staging</topic><topic>Orbital Neoplasms - drug therapy</topic><topic>Orbital Neoplasms - epidemiology</topic><topic>Orbital Neoplasms - pathology</topic><topic>Orbital Neoplasms - radiotherapy</topic><topic>Prednisone - administration & dosage</topic><topic>Radiotherapy, High-Energy - adverse effects</topic><topic>Retrospective Studies</topic><topic>Survival Analysis</topic><topic>Treatment Outcome</topic><topic>Vincristine - administration & dosage</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>SASAI, Keisuke</creatorcontrib><creatorcontrib>YAMABE, Hirohiko</creatorcontrib><creatorcontrib>DODO, Yoshihiro</creatorcontrib><creatorcontrib>KASHII, Satoshi</creatorcontrib><creatorcontrib>NAGATA, Yasushi</creatorcontrib><creatorcontrib>HIRAOKA, Masahiro</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Acta oncologica</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>SASAI, Keisuke</au><au>YAMABE, Hirohiko</au><au>DODO, Yoshihiro</au><au>KASHII, Satoshi</au><au>NAGATA, Yasushi</au><au>HIRAOKA, Masahiro</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Non-hodgkin's lymphoma of the ocular adnexa</atitle><jtitle>Acta oncologica</jtitle><addtitle>Acta Oncol</addtitle><date>2001-01-01</date><risdate>2001</risdate><volume>40</volume><issue>4</issue><spage>485</spage><epage>490</epage><pages>485-490</pages><issn>0284-186X</issn><eissn>1651-226X</eissn><coden>ACTOEL</coden><abstract>This study investigates the relationship between the clinical features of lymphoma in the ocular adnexal region and the revised European and American lymphoma (REAL) classification. Specimens from 41 patients with ocular adnexal lymphoproliferative disease were reassessed pathologically using the REAL classification. Thirty-two patients with primary non-Hodgkin's lymphomas (NHL) were included in the study, almost all of them having been treated with radiotherapy with or without chemotherapy. Seven of the 32 patients with NHL showed distant recurrence after treatment: 3 out of 26 with extranodal marginal zone B-cell lymphoma, and 4 with other types of NHL. Although the three patients with recurrent marginal zone B-cell lymphomas all survived, other patients with recurrent lymphomas died of disease. The REAL classification provides a good indication of tumor control probability and survival of patients with ocular adnexal NHL. Radiation therapy is an effective treatment modality for extranodal marginal zone B-cell lymphoma of the ocular adnexa.</abstract><cop>Basingstoke</cop><pub>Taylor & Francis</pub><pmid>11504308</pmid><doi>10.1080/028418601750288217</doi><tpages>6</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0284-186X |
| ispartof | Acta oncologica, 2001-01, Vol.40 (4), p.485-490 |
| issn | 0284-186X 1651-226X |
| language | eng |
| recordid | cdi_crossref_primary_10_1080_028418601750288217 |
| source | MEDLINE; EZB-FREE-00999 freely available EZB journals; Taylor & Francis Journals Complete |
| subjects | Adult Aged Aged, 80 and over Antineoplastic Combined Chemotherapy Protocols - administration & dosage Antineoplastic Combined Chemotherapy Protocols - therapeutic use Biological and medical sciences Chemotherapy, Adjuvant Cohort Studies Combined Modality Therapy Conjunctival Neoplasms - drug therapy Conjunctival Neoplasms - epidemiology Conjunctival Neoplasms - pathology Conjunctival Neoplasms - radiotherapy Cyclophosphamide - administration & dosage Disease-Free Survival Doxorubicin - administration & dosage Eyelid Neoplasms - drug therapy Eyelid Neoplasms - epidemiology Eyelid Neoplasms - pathology Eyelid Neoplasms - radiotherapy Female Hematologic and hematopoietic diseases Humans Immunoenzyme Techniques Immunophenotyping Japan - epidemiology Lacrimal Apparatus Diseases - drug therapy Lacrimal Apparatus Diseases - epidemiology Lacrimal Apparatus Diseases - pathology Lacrimal Apparatus Diseases - radiotherapy Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis Life Tables Lymphoma, Non-Hodgkin - drug therapy Lymphoma, Non-Hodgkin - epidemiology Lymphoma, Non-Hodgkin - pathology Lymphoma, Non-Hodgkin - radiotherapy Lymphoproliferative Disorders - epidemiology Lymphoproliferative Disorders - pathology Male Medical sciences Middle Aged Neoplasm Staging Orbital Neoplasms - drug therapy Orbital Neoplasms - epidemiology Orbital Neoplasms - pathology Orbital Neoplasms - radiotherapy Prednisone - administration & dosage Radiotherapy, High-Energy - adverse effects Retrospective Studies Survival Analysis Treatment Outcome Vincristine - administration & dosage |
| title | Non-hodgkin's lymphoma of the ocular adnexa |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T02%3A40%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Non-hodgkin's%20lymphoma%20of%20the%20ocular%20adnexa&rft.jtitle=Acta%20oncologica&rft.au=SASAI,%20Keisuke&rft.date=2001-01-01&rft.volume=40&rft.issue=4&rft.spage=485&rft.epage=490&rft.pages=485-490&rft.issn=0284-186X&rft.eissn=1651-226X&rft.coden=ACTOEL&rft_id=info:doi/10.1080/028418601750288217&rft_dat=%3Cpubmed_cross%3E11504308%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/11504308&rfr_iscdi=true |